Narcan medical direction and supplies

The Internal Revenue Service, specifically its Criminal Investigation division, has issued a forecast for a contract related to Narcan medical direction and supplies, aiming to secure medical oversight and distribution of naloxone for potential overdose response needs. The solicitation is classified under NAICS code 325412, which pertains to pharmaceutical preparation manufacturing, indicating the focus on both the medical guidance and physical supply components of Narcan. While no solicitation number or set-aside details are provided, the inclusion of "Yes" under type of set aside suggests potential preference for small business or socially disadvantaged vendors, though specifics remain undetermined. The point of contact for this initiative includes Christi Edwards as the Bureau Point of Contact and Tamela Hernandez as the Program Office Point of Contact, responsible for coordination and program execution. The place of performance and office address details are currently unspecified, leaving location-based logistics open to future clarification. The forecast was posted in May 2026, signaling an upcoming procurement opportunity that agencies and suppliers should prepare for as requirements are further defined.